Top

The journal of nutrition, health & aging

Published in:

01-05-2020 | Sarcopenia

Prevalence and Risk Factors Governing the Loss of Muscle Function in Elderly Sarcopenia Patients: A Longitudinal Study in China with 4 Years of Follow-Up

Authors: Y. Zhang, X. Chen, L. Hou, X. Lin, D. Qin, H. Wang, S. Hai, L. Cao, Birong Dong

Published in: The journal of nutrition, health & aging | Issue 5/2020

Abstract

Objectives

Data regarding the occurrence of risk factors that promote the loss of muscle mass, strength and function in sarcopenia patients in elderly Chinese patients are sparse. Here, we investigated the alterations in muscle mass, function and strength in those with sarcopenia over a 4-year period. We further evaluated the risk factors leading to a loss of grip strength, gait speed and skeletal muscle mass index in sarcopenia patients.

Design

A face-to-face cross-sectional survey.

Setting and Participants

The study population consisted of 560 Chinese aged over 59 years.

Measurements

Study recordings took places over a four-year period from 2014. Muscle mass was assessed through bioelectrical impedance analysis (BIA) performed on an Inbody720, Biospace. Hand-grip strength and 6 m walking speed were used as measurements of muscle strength and function. Sarcopenia was diagnosed using the Asian Working Group for Sarcopenia criteria (AWGS).

Results

In total, 474 of the elderly residents completed the follow-up. The rates of decreased ASMI, grip strength, and gait speed in the sarcopenia patients increased over the 4-year period. Following multivariate analysis, age was identified as the main risk factor for all the observed decrease, gender was specifically related to the loss of ASMI, stroke was a risk factor for gait speed and sarcopenia. A high BMI was a risk factor for a low gait speed but was protective for a loss of skeletal muscle mass and sarcopenia.

Conclusions

Age leads to a decline in muscle strength and function. In elderly Chinese patients with sarcopenia, the rates of reduced grip strength, gait-speed and sarcopenia increased. A high BMI was protective against the decline in muscle mass and sarcopenia, but represented a risk factor for low gait speed. Stoke was identified to cause a loss of gait speed in sarcopenia patients.

Rosenberg IH. Sarcopenia: Origins and Clinical Relevance. J Nutr. 1997;127(5):990S–991S. doi:https://doi.org/10.1093/jn/127.5.990s CrossRef

Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: A systematic review and meta-analysis. PLoS One. 2017; 12(1). doi:https://doi.org/10.1371/journal.pone.0169548

Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: A systematic review and meta-analysis. BMC Geriatr. 2017;17(1). doi:https://doi.org/10.1186/s12877-017-0569-2

Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr. 2018;37(4):1101–1113. doi:https://doi.org/10.1016/j.clnu.2017.07.010 CrossRef

Zhao Y, Zhang Y, Hao Q, Ge M, Dong B. Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res. 2019;31(1):5–14. doi:https://doi.org/10.1007/s40520-018-0931-z CrossRef

Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):48–759. doi:https://doi.org/10.1093/ageing/afu115 CrossRef

Wen X, An P, Chen WC, Lv Y, Fu Q. Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults. J Nutr Heal Aging. 2015;19(3):342–347. doi:https://doi.org/10.1007/s12603-014-0561-x CrossRef

Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 2017;83(1):229–239. doi:https://doi.org/10.1152/jappl.1997.83.1.229 CrossRef

Winegard KJ, Hicks AL, Vandervoort AA, Sale DG. a 12 Year Follow-Up Study of Ankle Muscle Function in Older Adults. Med Sci Sport Exerc. 1995;27(Supplement):S205. doi:https://doi.org/10.1249/00005768-199505001-01147 CrossRef

10.

Lynch NA, Metter EJ, Lindle RS, et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol. 2017;86(1): 188–194. doi:https://doi.org/10.1152/jappl.1999.86.1.188 CrossRef

11.

Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol. 2000;88(4): 1321–1326. doi:https://doi.org/10.1152/jappl.2000.88.4.1321 CrossRef

12.

Suetta C, Haddock B, Alcazar J, et al. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20–93 years. J Cachexia Sarcopenia Muscle. 2019;(April):jcsm.l2477. doi:https://doi.org/10.1002/jcsm.12477

13.

Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:https://doi.org/10.1093/ageing/afy169 CrossRef

14.

Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well-functioning cohort of older adults: The Health, Aging and Body Composition Study. J Am Geriatr Soc. 2003;51(3):323–330. doi:https://doi.org/10.1046/j.1532-5415.2003.51105.x CrossRef

15.

Beliaeff S, Bouchard DR, Hautier C, Brochu M, Dionne IJ. Association between muscle mass and isometric muscle strength in well-functioning older men and women. J Aging Phys Act. 2008;16(4):484–493. doi:https://doi.org/10.1123/japa.16.4.484 CrossRef

16.

Barbat-Artigas S, Rolland Y, Vellas B, Aubertin-Leheudre M. Muscle quantity is not synonymous with muscle quality. J Am Med Dir Assoc. 2013; 14(11):852.e1–852.e7. doi:https://doi.org/10.1016/j.jamda.2013.06.003 CrossRef

17.

Tey SL, Chew STH, How CH, et al. Factors associated with muscle mass in community-dwelling older people in Singapore: Findings from the SHIELD study. PLoS One. 2019; 14(10): 1–20. doi:https://doi.org/10.1371/journal.pone.0223222 CrossRef

18.

Hong S, Choi WH. The effects of sarcopenia and obesity on femur neck bone mineral density in elderly Korean men and women. Osteoporos Sarcopenia. 2016;2(2):103–109. doi:https://doi.org/10.1016/j.afos.2016.04.002 CrossRef

19.

Kirchengast S, Huber J. Mild Overweight Reduces the Risk of Sarcopenia in Healthy Women. Heal San Fr. 2010:62-68.

20.

Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014; 14(SUPPL. 1): 15–28. doi:https://doi.org/10.1111/ggi.12220 CrossRef

21.

Beavers KM, Beavers DP, Houston DK, et al. Associations between body composition and gait-speed decline: Results from the Health, Aging, and Body Composition study 1–4. Am J Clin Nutr. 2013;97(3):552–560. doi:https://doi.org/10.3945/ajcn.112.047860 CrossRef

22.

Stenholm S, Sainio P, Rantanen T, et al. High body mass index and physical impairments as predictors of walking limitation 22 years later in adult Finns. Journals Gerontol — Ser A Biol Sci Med Sci. 2007;62(8):859–865. doi:https://doi.org/10.1093/gerona/62.8.859 CrossRef

23.

Zoico E, Di Francesco V, Mazzali G, et al. High baseline values of fat mass, independently of appendicular skeletal mass, predict 2-year onset of disability in elderly subjects at the high end of the functional spectrum. Aging Clin Exp Res. 2007; 19(2): 154–159. doi:https://doi.org/10.1007/BF03324682 CrossRef

24.

Windham BG, Griswold ME, Wang W, et al. The Importance of Mid-to-Late-Life Body Mass Index Trajectories on Late-Life Gait Speed. Journals Gerontol — Ser A Biol Sci Med Sci. 2017;72(8):1130–1136. doi:https://doi.org/10.1093/gerona/glw200

25.

Scherbakov N, Doehner W. Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. J Cachexia Sarcopenia Muscle. 2011;2(1):5–8. doi:https://doi.org/10.1007/s13539-011-0024-8 CrossRef

26.

Ryan AS, Ivey FM, Serra MC, Hartstein J, Hafer-Macko CE. Sarcopenia and Physical Function in Middle-Aged and Older Stroke Survivors. Arch Phys Med Rehabil. 2017;98(3):495–499. doi:https://doi.org/10.1016/j.apmr.2016.07.015 CrossRef

27.

Matsushita T, Nishioka S, Taguchi S, Yamanouchi A. Sarcopenia as a predictor of activities of daily living capability in stroke patients undergoing rehabilitation. Geriatr Gerontol Int. 2019. doi:https://doi.org/10.1111/ggi.13780

28.

Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease: Lessons from gerontology. Chron Respir Dis. 2017;14(1):85–99. doi:https://doi.org/10.1177/1479972316679664 CrossRef

29.

Kurniawan A. Sarcopenia in Cancer Patients. Indones J Cancer. 2019; 13(3):96. doi:https://doi.org/10.33371/ijoc.v13i3.628 CrossRef

30.

Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–1244. doi:https://doi.org/10.1016/j.jhep.2016.07.040 CrossRef

31.

Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Hear Fail. 2017;4(4):492–498. doi:https://doi.org/10.1002/ehf2.12237 CrossRef

Title: Prevalence and Risk Factors Governing the Loss of Muscle Function in Elderly Sarcopenia Patients: A Longitudinal Study in China with 4 Years of Follow-Up
Authors: Y. Zhang
X. Chen
L. Hou
X. Lin
D. Qin
H. Wang
S. Hai
L. Cao
Birong Dong
Publication date: 01-05-2020
Publisher: Springer Paris
Keyword: Sarcopenia
Published in: The journal of nutrition, health & aging / Issue 5/2020
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-020-1361-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Design

Setting and Participants

Measurements

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2020

Prevention of COVID-19 in Older Adults: A Brief Guidance from the International Association for Gerontology and Geriatrics (IAGG) Asia/Oceania Region

The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection,

Prevalence and Its Associated Factors of Physical Frailty and Cognitive Impairment: Findings from the West China Health and Aging Trend Study (WCHAT)

Malnutrition and Physical Frailty among Nursing Home Residents: A Cross-Sectional Study in China

Staying True to the Calling of Geriatric Medicine Amid the Waves of COVID-19

Tele-ICU in the Age of COVID-19: Built for This Challenge

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials